Derivatives exchange volumes still declining

Derivatives trading volumes continued to fall across several leading exchanges in July.

At Frankfurt-based Eurex, the average daily volume (ADV) in July was 9.5 million contracts compared with 10.7 million in June. A similar pattern occurred at the Chicago Mercantile Exchange (CME), where the ADV for July was 9.8 million contracts compared with 11.4 million in the previous month. Futures and options volumes at the Hong Kong Exchange (HKEx) also dropped to a monthly total of 7.94 million compared with 9.17 million in June.

There were particularly large declines in equity derivatives volumes. Eurex saw equity index derivatives drop to a monthly total volume of 65 million contracts compared with 71.1 million in June, and equity options and single-stock futures reached a monthly total of 24.7 million contracts compared with 30.2 million. Similarly, CME E-mini equity index volume averaged 2.4 million contracts per day, compared with 2.8 million the month before, and equity standard volume averaged 96,000 contracts per day compared with 154,000 in June.

Volumes for interest rate derivatives also fell sharply. At Eurex, a total of 34 million contracts were traded in the interest rate derivatives segment in the month of July, down from 45 million in June. CME Group interest rate volume averaged 4.2 million contracts per day, down from an ADV of 5.1 million contracts in June.

"We are experiencing a slowdown in the whole economy. Credit has been tight, which has been reflected in our volumes. However, what is important is that customers are still using our contracts to hedge and manage risk. Volume declines have not been across the board with some products performing very well," said Mary Haffenberg, associate director for commodity and equity products at CME.

These results appear to be part of a larger trend of decline that has seen volumes fall well below those recorded this time last year. At Eurex, ADV this July dropped by 30.5% from the same month in 2008, while at CME, ADV was down 25%. At HKEx futures and options were down 5.1% from last July.

IntercontinentalExchange (Ice), however, has bucked the trend, achieving large volume increases and even record highs in some product areas last month. ADV for Ice's futures markets was more than a million contracts, an increase of 34% from July 2008. Ice Futures Europe established a monthly volume record of 15.8 million, with volume records set in a number of contracts, including European gas oil and EU emissions futures.

This success is partly due to new acquisitions and an expanded product range. New products, such as Ice ECX Emissions, are growing rapidly, although benchmark products such as Brent crude oil are also seeing healthy growth. Its new clearing platforms Ice Trust and Ice Clear Europe have also had an impact.

Commenting on the results, Ice chief financial officer Scott Hill said: "Second-quarter volume growth was driven in gas and oil as well as coal and emission futures. Our European Brent crude contract volume also remains relatively strong due to the growing recognition of its importance as a benchmark for global oil prices. July's numbers in our energy futures markets remain strong, including European Brent with ADV growth of 36%."

Ice may also see further rises in volumes with the rollout of a single-name clearing framework in September in both the US and Europe, subject to regulatory approval.

See also: Exchanges see drop in volumes
BIS shows first OTC derivatives market decline
BIS: decline slowing on derivatives exchanges
Eurex trading volume nudges ahead of CME
Trading volumes surge as Lehman clients rehedge

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here